Lufax Holding on Track for Record Low Close — Data Talk
Lufax Holding Ltd Sponsored ADR Class A (LU) is currently at $2.17, down $0.10 or 4.19%
--Would be new all-time low (Based on available data back to Oct. 30, 2020)
--Currently down seven consecutive days; down 23.95% over this period
--Longest losing streak since July 8, 2021, when it fell for nine straight trading days
--Worst seven day stretch since the seven days ending Dec. 26, 2023, when it fell 26.52%
--Down 29.15% month-to-date
--Down 29.15% year-to-date
--Down 97.24% from its all-time closing high of $78.88 on Nov. 16, 2020
--Down 78.59% from 52 weeks ago (Jan. 18, 2023), when it closed at $10.16
--Down 83.47% from its 52-week closing high of $13.16 on Feb. 1, 2023
--Would be a new 52-week closing low
--Traded as low as $2.14; new all-time intraday low (Based on available data back to Oct. 30, 2020)
--Down 5.73% at today's intraday low
All data as of 1:02:40 PM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
January 17, 2024 13:20 ET (18:20 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks